Is the future induction T-DXd followed by tailored maintenance?
Drs. Pegram and Yan discuss MRD, biomarkers, and why HER2+ metastatic care is entering a personalized era.
Induction, Maintenance & MRD: The Future of HER2+ Treatment
You may also like
Recommended Videos
